Pharmacy Medical News about Triptans

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Triptans: low utilization and high turnover in the general population
Cephalalgia, 09/04/09

Panconesi A et al. – The authors observed a low percentage of triptan users and a low rate of utilization, associated with a high percentage of discontinuation and new utilization (high turnover), without any substantial increase in triptans utilization during the years. All these data probably do not support optimal satisfaction with triptan therapy.

<< Previous
Long-term daclizumab therapy in relapsing-remitting multiple...

Next >>
What do pregnant women know about non-steroidal anti-inflammatory...

Clinical and Economic Comparison of Frovatriptan Versus other Oral Triptans in the Treatment of Acute Migraine in the Real-World Setting
Clinical Drug Investigation, 10/15/09 Relevance Score: 92%

Safety and Tolerability of Short-Term Preventive Frovatriptan: A Combined Analysis
Headache: The Journal of Head and Face Pain, 10/15/09 Relevance Score: 80%

Expanding Access to Triptans: Assessment of Clinical Outcome
Headache: The Journal of Head and Face Pain, 10/12/09 Relevance Score: 80%

New drugs for migraine
The Journal of Headache and Pain, 10/05/09 Relevance Score: 80%

Postmarketing migraine survey of frovatriptan: effectiveness and tolerability vs previous triptans, NSAIDs or a combination
Current Medical Research and Opinion, 10/01/09 Relevance Score: 80%